XORTX Therapeutics (XRTX) Current Assets (2020 - 2026)

XORTX Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $744416.0 for Q1 2026.

• Quarterly Current Assets fell 64.61% year-over-year to $744416.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $744416.0 (down 64.61% YoY) and the FY2025 annual result came in at $1.3 million, down 52.89% from the prior year.
• Current Assets was $744416.0 for Q1 2026 at XORTX Therapeutics, down from $1.3 million in the prior quarter.
• Across five years, Current Assets topped out at $10.9 million in Q4 2022 and bottomed at $744416.0 in Q1 2026.
• A 5-year average of $3.6 million and a median of $2.7 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets slumped 32.1% — and 2026, when it plunged 64.61%.
• XORTX Therapeutics' Current Assets stood at $10.9 million in 2022, then slumped by 62.56% to $4.1 million in 2023, then slumped by 34.21% to $2.7 million in 2024, then sank by 52.89% to $1.3 million in 2025, then plunged by 40.97% to $744416.0 in 2026.
• Business Quant data shows XRTX's Current Assets at $744416.0 in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.